Skip to content

A critical analysis of lysergic acid diethylamide in the present light!

M. Baskaran, Saravanan Mani, T. Maheswari, S. Muthulakshmi, A. Jayasudha

International Journal of Advanced Psychiatric Nursing 2020 DOI: 10.33545/26641348.2020.v2.i1a.23 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics LSD
Key findings Argues that LSD's history moved from psychiatric research tool to prohibited drug with no accepted clinical use, and that its pharmacology and receptor and gene-expression effects justify further investigation of its potential as a treatment for addictions.

Abstract

Lysergic acid diethylamide (LSD) is a semisynthetic compound with solid psychoactive properties. Chemically related to serotonin LSD was initially hypothesized to produce a psychosis-like state.1 Afterward, LSD was accounted for to have benefits in the treatment of addictions. However, far reaching unpredictable use and reports of unfriendly impacts brought about the arrangement of LSD as an illegal medication with no acknowledged clinical use. This article audits LSD's celebrated history from its disclosure, to its utilization as an exploration instrument, trailed by it across the board relationship with the counterculture development of the 1960s, lastly to its resurrection as a medication with expected advantages in the treatment of addictions. LSD's pharmacology, phenomenology, impacts at synapse receptors, and consequences for examples of quality articulation are looked into. In view of a survey of the writing, it is reasoned that further examination into LSD's potential as a treatment for addictions is justified.

Comparable studies

Other narrative reviews on LSD, most cited first.

Citations in the library

Explore topics